Use of Veno-Arterial Extracorporeal Membrane Oxygenation in Takotsubo Syndrome Due to Methadone Poisoning
https://doi.org/10.23934/2223-9022-2026-15-1-174-183
Abstract
Background Opioid poisoning, including methadone, occupies one of the leading positions in the structure of acute chemical poisoning by narcotic drugs and is often accompanied by severe complications, often leading to death. One of such complications is Takotsubo syndrome – an acute condition characterized, as a rule, by reversible dysfunction of the left ventricular myocardium. In the development of serious complications, standard therapeutic approaches to those patients are often insufficiently effective, which necessitates the use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO). This method serves not only to support vital functions, but also to correct metabolic disorders, creating optimal conditions for the recovery of the body.
The aim of this work was to demonstrate clinical experience of using veno-arterial extracorporeal membrane oxygenation in severe methadone poisoning complicated by the development of Takotsubo syndrome.
Results Patient S., 21 years old, was found at home in a state of depressed consciousness and respiration. At the time of examination by the ambulance team: level of consciousness and response to stimuli were reduced (GCS 5), bradypnea, bradycardia, severe arterial hypotension, signs of aspiration of gastric contents. The time spent in a comatose state was unknown. The patient was provided with first aid, including tracheal intubation, mechanical ventilation, and vasopressor support with norepinephrine. After that, the patient was urgently hospitalized in the intensive care unit of a city clinical hospital. Despite the intensive care, progression of signs of cardiac and respiratory failure was noted. On the 4th day, the patient was transferred to the intensive care unit of the regional vascular center (ICU RVC) of the N.V. Sklifosovsky Research Institute for Emergency Medicine. Based on the results of instrumental and laboratory tests, the following diagnosis was established: “Methadone poisoning. Toxic cardiomyopathy. Unspecified Takotsubo syndrome. Acquired long QT syndrome. Cardiac arrest with successful restoration of cardiac activity. Hospital-acquired bilateral polysegmental pneumonia. Purulent tracheobronchitis. Toxic encephalopathy”. Due to the development of refractory cardiogenic shock, the use of VA ECMO was initiated. On the 11th day, against the background of persistent stabilization of cardiorespiratory function, the patient was successfully weaned from the VA ECMO system. On the 12th day from the moment of hospitalization, the patient was transferred to the specialized toxicology intensive care unit to continue complex therapy. On the 31st day, the patient was discharged from the N.V. Sklifosovsky Research Institute for Emergency Medicine in a stable somatic condition.
Conclusion The presented observation demonstrates the high efficiency and feasibility of using VA ECMO in refractory cardiogenic shock caused by severe methadone poisoning with the development of Takotsubo syndrome.
Keywords
About the Authors
E. Z. AlievRussian Federation
Elnur Z.o. Aliev - Anesthesiologist-Resuscitator, Intensive Care Unit, Regional Vascular Center.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090
A. Y. Simonova
Russian Federation
Anastasia Yu. Simonova - Candidate of Medical Sciences, Leading Researcher, Department of Acute Poisoning and Somatopsychiatric Disorders, N.V. Sklifosovsky RIEM; Chief Consultant Toxicologist, Department of Healthcare of the City of Moscow; Acting Head, Department of Clinical Toxicology, RMA of Continuing Professional Education; Senior Researcher, Yu.M. Lopukhin Federal Research and Clinical Center for Physical and Chemical Medicine of the Federal Medical and Biological Agency of Russia.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090; Barrikadnaya Str. 2/1, bldg. 1, Moscow, 123242; Malaya Pirogovskaya Str. 1а, Moscow, 119435
D. A. Kosolapov
Russian Federation
Denis A. Kosolapov - Candidate of Medical Sciences, Head, Scientific Department of Resuscitation for Patients with Cardiovascular Pathology.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090
M. M. Potskhveria
Russian Federation
Mikhail M. Potskhveriya - Doctor of Medical Sciences, Head, Scientific Department of Acute Poisoning and Somatopsychiatric Disorders, N.V. Sklifosovsky RIEM; Professor of the Department of Clinical Toxicology, RMA PE.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090; Barrikadnaya Str. 2/1, bldg. 1, Moscow, 123242
A. M. Talyzin
Russian Federation
Aleksey M. Talyzin - Candidate of Medical Sciences, Head, Department of Anesthesiology and Resuscitation No. 3, Senior Researcher.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090
N. V. Astafiev
Russian Federation
Nikolay V. Astafyev - Head, Intensive Care Unit, Regional Vascular Center.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090
M. V. Golubeva
Russian Federation
Maria V. Golubeva - Resident, Specializing in Anesthesiology and Resuscitation.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090
M. A. Zhogoleva
Russian Federation
Maria A. Zhogoleva - Functional Diagnostics Physician, Department of Functional Diagnostics.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090
D. A. Kozlov
Russian Federation
Danil A. Kozlov - Cardiologist, Department of Emergency Cardiology.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090
A. D. Leonova
Russian Federation
Anna D. Leonova - Cardiologist, Department of Emergency Cardiology.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090
S. S. Petrikov
Russian Federation
Sergey S. Petrikov - Academician of the Russian Academy of Sciences, Doctor of Medical Sciences, Director.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090
T. T. Tkeshelashvili
Russian Federation
Tengiz T. Tkeshelashvili - Head, Department of Resuscitation and Intensive Care for Emergency Detoxification.
Bolshaya Sukharevskaya Sq. 3, Moscow, 129090
References
1. Daugherty LE. Extracorporeal membrane oxygenation as rescue therapy for methadone-induced pulmonary edema. Pediatr Emerg Care. 2011;27(7):633–634. PMID:21730798 https://doi.org/10.1097/PEC.0b013e3182225161
2. Beurton A, Goncalves R, Imbault J, Repusseau B, Ouattara A. Refractory cardiogenic shock caused by methadone poisoning and treated with hybrid extracorporeal membrane oxygenation. Therapie. 2022;77(6):737–739. PMID: 35300873 https://doi.org/10.1016/j.therap.2022.02.004
3. Zavaliy LB, Petrikov SS, Simonova AY, Potskhveriya MM, Zaker F, Ostapenko YN, et al. Diagnosis and treatment of persons with acute thallium poisoning. Toxicol Rep. 2021;8:277–281. PMID: 33552926 https://doi.org/10.1016/j.toxrep.2021.01.013
4. Upchurch C, Blumenberg A, Brodie D, MacLaren G, Zakhary B, Hendrickson RG. Extracorporeal membrane oxygenation use in poisoning: a narrative review with clinical recommendations. Clin Toxicol (Phila). 2021;59(10):877–887. PMID: 34396873 https://doi.org/10.1080/15563650.2021.1945082
5. Hoffman RS, Nelson LS, Howland MA, Lewin NA, Flomenbaum NE, Goldfrank LR (eds). Goldfrank’s Manual of Toxicologic Emergencies. New York: McGraw Hill Professional, 2007. (Rus. Ed.: Khoffman R, Nel’son L, Khauland ME, L’yuin N, Flomenbaum N, Goldfrank L. Ekstrennaya meditsinskaya pomoshch’ pri otravleniyakh. Moscow: Praktika Publ.; 2010)
6. Morley-Smith AC, Lyon AR, Omerovic E. Takotsubo cardiomyopathy. Br J Hosp Med (Lond). 2013;74(2):96–103. PMID: 23411979 https://doi.org/10.12968/hmed.2013.74.2.96
7. Movahed A, Reeves WC, Mehta PM, Gilliland MG, Mozingo SL, Jolly SR. Norepinephrine-induced left ventricular dysfunction in anesthetized and conscious, sedated dogs. Int J Cardiol. 1994;45(1):23–33. PMID: 7995660 https://doi.org/10.1016/0167-5273(94)90051-5
8. Choi JH, Oh ID, Shin E, Lee S, Jeon JM, Kim HT, et al. Extracorporeal membrane oxygenation for takotsubo cardiomyopathy that developed after mitral valve replacement. Acute Crit Care. 2020;35(1):51–55. PMID: 31743637 https://doi.org/10.4266/acc.2018.00304
9. Alekhin MN. Syndrome Takotsubo: of Value of Echocardiography. Kardiologiia. 2017;57(7):80–89. (In Russ.) https://doi.org/10.18087/cardio.2017.7.10009
10. Lemesle F, Lemesle F, Nicola W, Pierre Jonville-Bera A. First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction. Am J Emerg Med. 2010;28(3):387.e5–6. PMID: 20223408 https://doi.org/10.1016/j.ajem.2009.07.007
11. Dehghani K, Shojaie M, Pourdavood AH, Khajouei M. Stress cardiomyopathy (Takotsubo syndrome) following accidental methadone poisoning; report of two pediatric cases. Arch Acad Emerg Med. 2019;7(1):e22. PMID: 31432032
12. Rojas-Marte G, John J, Sadiq A, Moskovits N, Saunders P, Shani J. Medication-induced Takotsubo Cardiomyopathy presenting with cardiogenic shock-utility of extracorporeal membrane oxygenation (ECMO): case report and review of the literature. Cardiovasc Revasc Med. 2015;16(1):47–51. PMID: 25172356 https://doi.org/10.1016/j.carrev.2014.07.004
13. Shmotkina AO, Shilova AS, Giliarova EM, Bakradze LM, Giliarov MYu. Takotsubo syndrome in critically ill patients in a Moscow multi-field hospital. Russian Journal of Anesthesiology and Reanimatology. 2019;(1):44–49. (In Russ.) https://doi.org/10.17116/anaesthesiology201901144
14. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–548. PMID: 15703419 https://doi.org/10.1056/NEJMoa043046
15. Perifericheskaya veno-arterial’naya ekstrakorporal’naya membrannaya oksigenatsiya pered transplantatsiey serdtsa: Natsional’nye klinicheskie rekomendatsii. Moscow; 2015. (In Russ.) Available at: https://transpl.ru/files/rto/perefer-abo-pered-transpl.pdf [Accessed Jan 25, 2025]
16. Lyon A, Rees P, Prasad S, Poole-Wilson PA, Harding SE. Stress (Takotsubo) cardiomyopathy-a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med. 2008;5(1):22–29. PMID: 18094670 https://doi.org/10.1038/ncpcardio1066
17. Azzarelli S, Galassi AR, Amico F, Giacoppo M, Argentino V, Tomasello SD, et al. Clinical features of transient left ventricular apical ballooning. Am J Cardiol. 2006;98(9):1273–1276. PMID: 17056345 https://doi.org/10.1016/j.amjcard.2006.05.065
18. Grayburn PA, Hillis LD. Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med. 2003;138(6):506–511. PMID: 12639086 https://doi.org/10.7326/0003-4819-138-6-200303180-00017
19. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008;155(3):408–417. PMID: 18294473 https://doi.org/10.1016/j.ahj.2007.11.008
20. Madhavan M, Prasad A. Proposed Mayo Clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis. Herz. 2010;35(4):240–244. PMID: 20582391 https://doi.org/10.1007/s00059-010-3339-x
21. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004;141(11):858–865. PMID: 15583228 https://doi.org/10.7326/0003-4819-141-11-200412070-00010
22. Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, et al. Acute and Reversible Cardiomyopathy Provoked by Stress in Women from the United States. Circulation. 2005;111(4):472–479. PMID: 15687136 https://doi.org/10.1161/01.CIR.0000153801.51470.EB
23. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J. 2006;27(13):1523–1529. PMID: 16720686 https://doi.org/10.1093/eurheartj/ehl032
24. Schneider B, Athanasiadis A, Stöllberger C, Pistner W, Schwab J, Gottwald U, et al. Gender differences in the manifestation of takotsubo cardiomyopathy. Int J Cardiol. 2013;166(3):584–588. PMID: 22192296 https://doi.org/10.1016/j.ijcard.2011.11.027
25. Citro R, Rigo F, D’Andrea A, Ciampi Q, Parodi G, Provenza G, et al.; Tako-Tsubo Italian Network Investigators. Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital mortality in Takotsubo cardiomyopathy. JACC Cardiovasc Imaging. 2014;7(2):119–129. PMID: 24412188 https://doi.org/10.1016/j.jcmg.2013.09.020
26. Schneider B, Athanasiadis A, Schwab J, Pistner W, Gottwald U, Schoeller R, et al. Complications in the clinical course of takotsubo cardiomyopathy. Int J Cardiol. 2014;176(1):199–205. PMID: 25049018 https://doi.org/10.1016/j.ijcard.2014.07.002
27. Ali M, Adam O, Subahi A, Awadelkarim A, Fatiwala L, Singh MM, et al. Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient. J Investig Med High Impact Case Rep. 2021;9:23247096211005100. PMID: 33843317 https://doi.org/10.1177/23247096211005100
28. Albenque G, Bohbot Y, Delpierre Q, Tribouilloy C. Basal takotsubo syndrome with transient severe mitral regurgitation caused by drug use: A case report. Eur Heart J Case Rep. 2020;4(2):1–6. PMID: 32864562 http://doi.org/10.1093/ehjcr/ytaa028 eCollection 2020 Jun.
29. Solhjoo S, Punjabi NM, Ivanescu AE, Crainiceanu C, Gaynanova I, Wicken C, et al. Methadone Destabilizes Cardiac Repolarization During Sleep. Clin Pharmacol Ther. 2021;110(4):1066–1074. PMID: 34287835 https://doi.org/10.1002/cpt.2368
30. Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf. 2005;14(11):747–753. PMID: 15918160 https://doi.org/10.1002/pds.1112
31. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med. 2002;137(6):501–504. PMID: 12230351 https://doi.org/10.7326/0003-4819-137-6-200209170-00010
32. Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA. 2003;289(16):2120–2127. PMID: 12709470 https://doi.org/10.1001/jama.289.16.2120
33. Katchman AN, McGroary KA, Kilborn MJ, Kornick CA, Manfredi PL, Woosley RL, et al. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther. 2002;303(2):688–694. PMID: 12388652 https://doi.org/10.1124/jpet.102.038240
34. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350(10):1013–1022. PMID: 14999113 https://doi.org/10.1056/NEJMra032426
35. Zhuravel SV., Kosolapov DA, Ketskalo MV. The Organization of Extracorporeal Membrane Oxygenation Programs for Acute Respiratory Failure in Adult Patients in a multidisciplinary hospital. Review of Experience in Regensburg (Germany). Transplantologiya. The Russian Journal of Transplantation. 2014;(4):28–32.
36. Afshari R, Maxwell S, Bateman D. Hemodynamic effects of methadone and dihydrocodeine in overdose. Clin Toxicol (Phila). 2007;45(7):763–772. PMID: 17852162 https://doi.org/10.1080/15563650701502691
37. Simonova AYu, Potskhveriya MM, Zhuravel SV, Petrikov SS, Talyzin AM. The Role of Extracorporeal Membrane Oxygenation in the Complex Treatment of Acute Chemical Poisoning. Russian Sklifosovsky Journal Emergency Medical Care. 2023;12(3):448–457. https://doi.org/10.23934/2223-9022-2023-12-3-448-457 (in Russ.)
38. Ng M, Wong ZY, Ponampalam R. Extracorporeal cardio-pulmonary resuscitation in poisoning: A scoping review article. Resusc Plus. 2023;13:100367. PMID: 36860990 https://doi.org/10.1016/j.resplu.2023.100367
Review
For citations:
Aliev E.Z., Simonova A.Y., Kosolapov D.A., Potskhveria M.M., Talyzin A.M., Astafiev N.V., Golubeva M.V., Zhogoleva M.A., Kozlov D.A., Leonova A.D., Petrikov S.S., Tkeshelashvili T.T. Use of Veno-Arterial Extracorporeal Membrane Oxygenation in Takotsubo Syndrome Due to Methadone Poisoning. Russian Sklifosovsky Journal "Emergency Medical Care". 2026;15(1):174-183. (In Russ.) https://doi.org/10.23934/2223-9022-2026-15-1-174-183
JATS XML





































.jpg)